The findings of Phase 3 study are in line with Phase 2 study conducted in the US and Europe
Demonstrate significant bleed reduction in hemophilia A and B
Digitally enabled drug discovery for oncology with potential to accelerate the delivery of new cancer therapies to patients
The company expects that this development could improve the strength of its application to the FDA for new drug approval
ASMD is highly variable and the age of onset, specific symptoms and severity of the disorder can vary dramatically from one person to another
Over 34 lakh children and 6 lakh pregnant women were administered vaccine doses during the first 2 rounds of IMI 5.0 campaign across the country
The discoveries by the two Nobel Laureates were critical for developing effective mRNA vaccines against COVID-19
SigTuple’s AI100 with Shonit is the premier solution for AI assisted digital pathology
The investment will help the company meet soaring demand for user-friendly oral dosage form development and manufacturing
Public private partnership (PPP) with integrated strategy essential to achieve ‘TB Mukt Bharat’ by 2025
Subscribe To Our Newsletter & Stay Updated
